NEW YORK (GenomeWeb News) – GenMark Diagnostics has received US Food and Drug Administration 510(k) clearance for its eSensor Respiratory Virus Panel.

The test simultaneously detects and differentiates 14 clinically relevant viruses from patients with influenza-like illness. According to GenMark, it has the "potential to significantly improve patient care by delivering superior co-infection detection, distinguishing rhinovirus from enteroviruses and identifying clinically relevant adenoviruses."

The test runs on the firm's eSensor XT-8 system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.